Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Blinded, Sham-Controlled Trial of Acupuncture on the Progression of Mild Alzheimer's Disease

NCT05078944 is registered in ClinicalTrials.gov with Shanghai Institute of Acupuncture, Moxibustion and Meridian as lead sponsor.

NCT NCT05078944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05078944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Blinded, Sham-Controlled Trial of Acupuncture on the Progression of Mild Alzheimer's Disease
Lead sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2022
Completion date
September 10, 2025
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease 1